Updated practice guideline for dual-energy X-ray absorptiometry (DXA).

Autor: Slart RHJA; Medical Imaging Centre, Department of Nuclear Medicine & Molecular Imaging (EB50), University Medical Center Groningen, University of Groningen, Hanzeplein 1, PO 9700 RB, Groningen, The Netherlands. r.h.j.a.slart@umcg.nl., Punda M; Department of Oncology and Nuclear Medicine, University Hospital Centre Sestre Milosrdnice, Vinogradska 29, Zagreb, Croatia., Ali DS; Department of Endocrinology, McMaster University, Hamilton, L8S 4L8, Canada., Bazzocchi A; Diagnostic and Interventional Radiology, IRCCS Istituto Ortopedico Rizzoli, Via G. C. Pupilli 1, Bologna, 40136, Italy., Bock O; Department of Osteoporosis, Inselspital, Bern University Hospital, Switzerland, IG Osteoporose, Bern, Switzerland., Camacho P; Loyola University Medical Center (LUMC), 2160 S 1st Ave, Maywood, IL, 60153, USA., Carey JJ; University of Galway, Galway, H91 V4AY, Ireland., Colquhoun A; Centre for Osteoporosis & Bone Health, Women's College Hospital, Toronto, ON, Canada., Compston J; Cambridge Biomedical Centre, Cambridge, UK., Engelke K; Department of Medicine, Institute of Medical Physics, FAU University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Ulmenweg 18, 91054, Erlangen, Germany., Erba PA; Department of Medicine and Surgery, Nuclear Medicine Unit, ASST Ospedale Papa Giovanni, University of Milan-Bicocca, Piazza, Bergamo, Italy., Harvey NC; MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton General Hospital, Southampton, UK.; NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital NHS Foundation Trust, Southampton, UK., Krueger D; School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA., Lems WF; Department of Rheumatology, Amsterdam University Medical, Center, The Netherlands., Lewiecki EM; New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM, 87106, USA., Morgan S; The UAB Osteoporosis Prevention and Treatment Clinic, The University of Alabama at Birmingham, Birmingham, Al, USA., Moseley KF; Division of Endocrinology, Johns Hopkins University, Baltimore, MD, 21201, USA., O'Brien C; Brant Community Healthcare System, Brantford, ON, Canada., Probyn L; Department of Medical Imaging, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Ave., Toronto, ON, M4N 3M5, Canada., Rhee Y; Department of Internal Medicine, Endocrine Research Institute, Yonsei University College of Medicine, Seoul, Korea., Richmond B; Diagnostic Radiology, Cleveland Clinic Main Campus, 9500 Euclid Avenue, Cleveland, OH, 44195, USA., Schousboe JT; Park Nicollet Clinic and HealthPartners Institute, Minneapolis, MN, USA., Shuhart C; Swedish Bone Health and Osteoporosis Center, 1600 E Jefferson St Ste 300, Seattle, WA, 98122, USA., Ward KA; MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton General Hospital, Southampton, UK., Van den Wyngaert T; Department of Nuclear Medicine, Antwerp University Hospital, Antwerp, Belgium., Zhang-Yin J; Department of Nuclear Medicine, Clinique Sud Luxembourg, Vivalia, B-6700, Arlon, Belgium., Khan AA; Department of Endocrinology, McMaster University, Hamilton, L8S 4L8, Canada.
Jazyk: angličtina
Zdroj: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Sep 24. Date of Electronic Publication: 2024 Sep 24.
DOI: 10.1007/s00259-024-06912-6
Abstrakt: The introduction of dual-energy X-ray absorptiometry (DXA) technology in the 1980s revolutionized the diagnosis, management and monitoring of osteoporosis, providing a clinical tool which is now available worldwide. However, DXA measurements are influenced by many technical factors, including the quality control procedures for the instrument, positioning of the patient, and approach to analysis. Reporting of DXA results may be confounded by factors such as selection of reference ranges for T-scores and Z-scores, as well as inadequate knowledge of current standards for interpretation. These points are addressed at length in many international guidelines but are not always easily assimilated by practising clinicians and technicians. Our aim in this report is to identify key elements pertaining to the use of DXA in clinical practice, considering both technical and clinical aspects. Here, we discuss technical aspects of DXA procedures, approaches to interpretation and integration into clinical practice, and the use of non-bone mineral density measurements, such as a vertebral fracture assessment, in clinical risk assessment.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz: